Spruce Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Javier Szwarcberg, with a market cap of $142.6M.
Based on Q1 2026 filing
Common questions about Spruce Biosciences, Inc.
Spruce Biosciences, Inc. (SPRB) has a market capitalization of $142.6M and trades on NASDAQ.
Spruce Biosciences, Inc. has approximately 22 employees.